Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.

Cusano NE, Rubin MR, McMahon DJ, Zhang C, Ives R, Tulley A, Sliney J Jr, Cremers SC, Bilezikian JP.

J Clin Endocrinol Metab. 2013 Jan;98(1):137-44. doi: 10.1210/jc.2012-2984. Epub 2012 Nov 15.

PMID:
23162103
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Therapy of hypoparathyroidism with intact parathyroid hormone.

Rubin MR, Sliney J Jr, McMahon DJ, Silverberg SJ, Bilezikian JP.

Osteoporos Int. 2010 Nov;21(11):1927-34. doi: 10.1007/s00198-009-1149-x. Epub 2010 Jan 22.

PMID:
20094706
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.

Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr.

J Clin Endocrinol Metab. 2010 Jun;95(6):2680-8. doi: 10.1210/jc.2009-2464. Epub 2010 Apr 14.

PMID:
20392870
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study.

Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L; Hypoparathyroid Study Group.

J Bone Miner Res. 2011 Oct;26(10):2358-70. doi: 10.1002/jbmr.470.

PMID:
21773992
[PubMed - indexed for MEDLINE]
5.

Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.

Winer KK, Zhang B, Shrader JA, Peterson D, Smith M, Albert PS, Cutler GB Jr.

J Clin Endocrinol Metab. 2012 Feb;97(2):391-9. doi: 10.1210/jc.2011-1908. Epub 2011 Nov 16.

PMID:
22090268
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure.

Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Zhou H, Dempster DW, Collins MT.

J Bone Miner Res. 2012 Aug;27(8):1811-20. doi: 10.1002/jbmr.1627.

PMID:
22492501
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP.

J Clin Endocrinol Metab. 2000 Sep;85(9):3069-76.

PMID:
10999788
[PubMed - indexed for MEDLINE]
8.

PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.

Sikjaer T, Amstrup AK, Rolighed L, Kjaer SG, Mosekilde L, Rejnmark L.

J Bone Miner Res. 2013 Oct;28(10):2232-43. doi: 10.1002/jbmr.1964.

PMID:
23649554
[PubMed - indexed for MEDLINE]
9.

Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement.

Rubin MR, Bilezikian JP.

Arq Bras Endocrinol Metabol. 2010 Mar;54(2):220-6.

PMID:
20485912
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.

Laway BA, Goswami R, Singh N, Gupta N, Seith A.

Clin Endocrinol (Oxf). 2006 Apr;64(4):405-9.

PMID:
16584512
[PubMed - indexed for MEDLINE]
11.

Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr.

J Clin Endocrinol Metab. 2003 Sep;88(9):4214-20.

PMID:
12970289
[PubMed - indexed for MEDLINE]
12.

Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.

Duan Y, De Luca V, Seeman E.

J Clin Endocrinol Metab. 1999 Feb;84(2):718-22.

PMID:
10022443
[PubMed - indexed for MEDLINE]
13.

Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis.

Black DM, Bilezikian JP, Greenspan SL, Wüster C, Muñoz-Torres M, Bone HG, Rosen CJ, Andersen HS, Hanley DA.

Osteoporos Int. 2013 Apr;24(4):1503-11. doi: 10.1007/s00198-012-2098-3. Epub 2012 Aug 29.

PMID:
22930240
[PubMed - indexed for MEDLINE]
14.

Use of parathyroid hormone in hypoparathyroidism.

Cusano NE, Rubin MR, Irani D, Sliney J Jr, Bilezikian JP.

J Endocrinol Invest. 2013 Dec;36(11):1121-7. Review.

PMID:
24445125
[PubMed - indexed for MEDLINE]
15.

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.

Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.

J Clin Endocrinol Metab. 1997 Feb;82(2):620-8.

PMID:
9024265
[PubMed - indexed for MEDLINE]
16.

Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.

Cosman F, Nieves J, Woelfert L, Formica C, Gordon S, Shen V, Lindsay R.

J Bone Miner Res. 2001 May;16(5):925-31.

PMID:
11341338
[PubMed - indexed for MEDLINE]
17.

Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.

Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.

J Bone Miner Res. 2004 Aug;19(8):1221-30. Epub 2004 May 24.

PMID:
15231008
[PubMed - indexed for MEDLINE]
18.

PTH replacement therapy of hypoparathyroidism.

Rejnmark L, Sikjaer T, Underbjerg L, Mosekilde L.

Osteoporos Int. 2013 May;24(5):1529-36. doi: 10.1007/s00198-012-2230-4. Epub 2012 Nov 27. Review.

PMID:
23184178
[PubMed - indexed for MEDLINE]
19.

Mini-review: new therapeutic options in hypoparathyroidism.

Cusano NE, Rubin MR, Sliney J Jr, Bilezikian JP.

Endocrine. 2012 Jun;41(3):410-4. doi: 10.1007/s12020-012-9618-y. Epub 2012 Feb 7. Review.

PMID:
22311174
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a five-year randomized controlled trial.

Zhu K, Devine A, Dick IM, Wilson SG, Prince RL.

J Clin Endocrinol Metab. 2008 Mar;93(3):743-9. Epub 2007 Dec 18.

PMID:
18089701
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk